C

노을

376930KOSDAQ의료용 기기 제조업

48.0 / 100

Reference Date: 2026-04-13

Financial Score8.5 / 40
News Sentiment22.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, Operating Profit is on a declining trend. Slightly up 1.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Noul is a company specializing in the development and sale of on-device AI solutions, 'miLab™', for blood and cancer diagnostics. By automating microscopic pathology processes and integrating AI-based diagnostic technology, miLab™ enables high-precision diagnostics even in environments lacking specialized personnel or infrastructure. The solution currently offers three applications—malaria diagnosis, peripheral blood smear analysis, and cervical cell analysis—and targets the mid-sized diagnostic lab market, where it holds a competitive advantage due to its offline capabilities and cost-effectiveness.

Number of Employees

130people

Average Salary

73.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 26.524.0Point
PBR
3.26Industry Average 1.701.0Point

1.9x industry avg (risky)

ROE
-87.04Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
21.04Industry Average 10.950.5Point

1.9x industry avg (risky)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲89.2% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼14.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -72.7% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 90

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 1,632Won52-week high 3,45852-week low 1,434
1-month return3.0Point

1m 1.12% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0
  • Neutral정기주주총회결과2026-03-31
  • Neutral사업보고서 (2025.12)2026-03-23
  • Neutral감사보고서제출2026-03-19
  • Neutral주주총회소집공고2026-03-16